 Home > Active Ingredient News > Blood System > JAMA Intern Med: Oral Daprodustat regimen for anemia in chronic kidney disease

JAMA Intern Med: Oral Daprodustat regimen for anemia in chronic kidney disease

 Last Update: 2022-04-15
 Source: Internet
 Author: User

Tags

8 common allergens

particle disease

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

Statistics found that the risk of death in the first 90 days after starting dialysis was twice as high as that in the following 9 months

Statistics Recently, researchers investigated the efficacy of oral hypoxia-inducible factor prolyl hydroxylase inhibitor Daprodustat in patients with recent CKD dialysis anemia

The study was conducted in 90 clinical centers in 14 countries, and patients with advanced CKD who started receiving hemodialysis (HD) or peritoneal dialysis (PD) 90 days before the start of the study participated, and the patient's hemoglobin (Hb) concentration was 8.

Of the 312 patients enrolled, mean age 55 years, 62% male, 157 received daprodustat and 155 received dabebor alfa, and 306 (98%) completed the study

The HD concentration during the evaluation period was 10.

Changes in HD level and iron injection amount between groups

The study concluded that Daprodustat is an effective oral erythropoiesis-stimulating treatment regimen for patients with anemia in chronic kidney disease as effective as dabepox alfa

Daprodustat is an effective oral erythropoiesis-stimulating treatment regimen that is comparable to dabepog alfa in patients with anemia in chronic kidney disease

Original source:

Ajay K.

Efficacy and Safety of Daprodustat for Treatment of Anemia of Chronic Kidney Disease in Incident Dialysis Patients A Randomized Clinical Trial JAMA

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Related Products

Pharmaceutical Grade 99% 2-Deoxy-D-ribose CAS: 533-67-5 Best Quality

CAS No.: 533-67-5

Pharmacy Grade;

$385-465/KG FOB

Best Quality 99% Semaglutide Semaglutide, Reta, AOD CAS:910463-68-2/782487-28-9 for Weight Loss

CAS No.: 910463-68-2

Pharmacy Grade;

$250-280/G FOB

High Quality GMP / FDA Certificated Liraglutide Powder CAS 204656-20-2 Liraglutide

CAS No.: 204656-20-2

Pharmacy Grade

$200-250/G FOB

Hot Tags

jobs united states(236)

united states jobs(223)

1 year treasury(277)

1 year subscription(296)

single use technology(195)

ups united states(221)

announcements today(81)

united states logo(227)

80 20 company(94)

healthy food name(42)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.